European Healthtech startup funding raised during Q4 2020.
In Q4 2020, 147 European Healthtech companies raised a combined €1.6B across 151 funding rounds, up 66.5% versus Q4 2019. Switzerland led by capital raised, and Fountain Healthcare Partners was the most active investor. Data as of 23 Aug 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Atai Life Sciences | Series C | Nov 2020 | €105M |
| Sophia Genetics | Series D+ | Oct 2020 | €94M |
| Vectivbio | Other | Oct 2020 | €94M |
| Pharvaris | Series C |
| Nov 2020 |
| €67M |
| Achilles Therapeutics | Other | Nov 2020 | €59M |
| CatalYm | Seed | Nov 2020 | €50M |
| MinervaX | Series B | Dec 2020 | €47M |
| Augury | Series D+ | Oct 2020 | €47M |
| Spineart | Other | Oct 2020 | €46M |
| Sparingvision | Other | Oct 2020 | €45M |
| MitrAssist | Other | Dec 2020 | €42M |
| Protalix Biotherapeutics | Other | Dec 2020 | €36M |
| K Health | Series D+ | Nov 2020 | €35M |
| Priothera Limited | Series A | Oct 2020 | €30M |
| Min Doktor | Other | Nov 2020 | €27M |
